Escitalopram treatment for premature ejaculation has a negative effect on semen parameters

International Journal of Impotence Research

Volumn 23, Issue 6, 2011, Pages 257-261

  Koyuncu, H ^a   Serefoglu, E C ^b   Yencilek, E ^c   Atalay, H ^a   Akbas, N B ^a   Sarca, K ^a  

^a YEDITEPE UNIVERSITY   (Turkey)

^b Department of Urology   (Turkey)

^c GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

escitalopram; premature ejaculation; selective serotonin reuptake inhibitors; semen analysis

Indexed keywords

ESCITALOPRAM;

ADULT; ARTICLE; CLINICAL ARTICLE; HEALTH SURVEY; HUMAN; MALE; MEDICAL HISTORY; MORPHOLOGY; OUTPATIENT; PREMATURE EJACULATION; PRIORITY JOURNAL; SCORING SYSTEM; SELF REPORT; SEXUAL BEHAVIOR; SIDE EFFECT; SPERM; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; TREATMENT DURATION;

ADULT; CITALOPRAM; EJACULATION; HUMANS; MALE; QUESTIONNAIRES; SEMEN; SEMEN ANALYSIS; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SPERM COUNT; SPERM MOTILITY; SPERMATOZOA;

EID: 80955142961     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2011.35     Document Type: Article

References (38)

1. Read S, King M, Watson J. Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med 1997; 19: 387-391. (Pubitemid 28031265)
2. Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidites, and professional help-seeking. Eur Urol 2007; 51: 816-824. (Pubitemid 46097263)
3. Patrick DL, Althof SE, Pryor JL. Premature ejaculation: an observational study of men and their partners. J Sex Med 2005; 2: 358-367. (Pubitemid 40744376)
4. Guliano F, Patrick DL, Porst H. Premature ejaculation: results from a five country european observational study. Eur Urol 2008; 53: 1048-1057. (Pubitemid 351434498)
5. Godpodinoff ML. Premature ejaculation: clinical subgroups and etiology. J Sex Marital Ther 1989; 15: 130-134. (Pubitemid 19213787)
6. McMahon CG, Althof S, Waldinger MD, Porst H, Dean J, Sharlip I et al. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine ad hoc committee for the definition of premature ejaculation. J Sex Med 2008; 5: 1590-1606. (Pubitemid 352044417)
7. Wespes E, Amar E, Eardly I, Giuliano F, Hatzichristou D, Hatzimouratidis K et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. European Association of Urology Guidelines. Drukkerij Gel-derlandbv: Arnhem-Netherlands, 2009; 33-46.
8. Montejo AL, Llorca G, Izquierdo JA, Rico-Willademoros F. Incidence of sexual dysfunction associated with antidepres-sant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the study of psycholotropic-related sexual dysfunction. J Clin Psychiatry 2001; 62: 10-21. (Pubitemid 32164676)
9. Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S. Summary of the recommendation on sexual dysfunctions in men. J Sex Med 2004; 1: 6-23. (Pubitemid 40424662)
10. Safarinejad MR. Sperm DNA damage and semen quality impairment after treatment with selective serotonin reuptake inhibitors detected using semen analysis and sperm chroma-tin structure assay. J Urol. 2008; 180: 2124-2128.
11. Tanrikut C, Feldman AS, Altemus M, Paduch DA, Schlegel PN. Adverse effect of paroxetine on sperm. Fertil Steril 2010; 94: 1021-1026.
12. Althof SE, Symonds T. Patient reported outcomes used in the assessment of premature ejaculation. Urol Clin North Am 2007; 34: 581-589. (Pubitemid 350029942)
13. Serefoglu EC, Cimen HI, Ozdemir AT, Symonds T, Berktas M, Balbay MD. Turkish validation of the premature ejaculation diagnostic tool and its association with intravaginal ejacula-tory latency time. Int J Impot Res 2009; 21: 139-144.
14. American Psychiatric Association. Diagnostic criteria from DSM-IV-TR. American Psychiatric Association: Washington, DC, 2000.
15. McMahon CG. Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies-part I-defining and selecting the study population. J Sex Med 2008; 5: 1805-1816.
16. McMahon CG. Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies-Part II-Study design, outcome measures, data analysis, and reporting. J Sex Med 2008; 5: 1817-1833.
17. Porst H, Vardi Y, Akkus E, Melman A, Park NC, Seftel AD et al. Standards for clinical trials in male sexual dysfunctions. J Sex Med 2010; 7: 414-444.
18. Symonds T, Perelman M, Althof S, Giuliano F, Martin M, Abraham L. Further evidence of the reliability and validity of the premature ejaculation diagnostic tool. Int J Impot Res 2007; 19: 521-525. (Pubitemid 47367530)
19. Arafa M, Shamloul R. Efficacy of sertraline hydrochloride in treatment of premature ejaculation: a placebo-controlled study using a validated questionnaire. Int J Impot Res 2006; 18: 534-538. (Pubitemid 44658546)
20. Giuliano F, Clement P. Serotonin and premature ejaculation: from physiology to patient management. Eur Urol 2006; 50: 454-466. (Pubitemid 44189074)
21. Waldinger MD, Zwinderman AH, Schweitzer DH. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 2004; 16: 369-381. (Pubitemid 39273766)
22. Safarinejad MR, Hosseini SY. Safety and efficacy of escitalo-pram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study. Int J Impot Res 2006; 18: 164-169. (Pubitemid 43336482)
23. Arafa M, Shamloul R. A randomized study examining the effect of 3 SSRI on premature ejaculation using a validated questionnaire. Ther Clin Risk Manag 2007; 3: 527-531. (Pubitemid 47496956)
24. Safarinejad RM. Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study. J Clin Psychophar-macol 2007; 27: 444-450.
25. Guiliano F, Hellstrom W. The pharmacological treatment of premature ejaculation. BJUI 2008; 102: 668-675.
26. Tamam L, Ozpoyraz N. Selective serotonin reuptake inhibitor discontinuation syndrome: a review. Adv Ther 2002; 19: 17-26. (Pubitemid 34438984)
27. Haddad P. The SSSRI discontinuation syndrome. J Psycho-pharmacol 1998; 12: 305-313.
28. Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 1997; 17: 208-221. (Pubitemid 27261777)
29. De Lamirande E, Gagnon C. Paradoxical effect of reagents for sulfhydryl and disulfide groups on human sperm capacitation and superoxide production. Free Radic Biol Med 1998; 257: 803-817. (Pubitemid 28512533)
30. De Lamirande E, Gagnon C. Redox control of changes in protein sulfhydryl levels during human sperm capacitation. Free Radic Biol Med 2003; 35: 1271-1285. (Pubitemid 37357252)
31. Wolf WA, Kuhn DM. Role of essential sulfhdryl groups in drug interactions at the neuronal 5-HT transporter. Differences between amphetamines and 5-HT uptake inhibitors. J Biol Chem 1992; 267: 20820-20825.
32. Kumar K, Sharma LV, Tiwari P, Singh D, Maikhuri JP, Gupta G et al. The spermicidal and antitrichomonas activities of SSRI antidepressants. Bioorg Med Chem Lett 2006; 16: 2509-2512.
33. Tanrikut C, Schegel PN. Antidepressant-associated changes in semen parameters. Urology 2007; 69: 185-187.
34. Amann RP. The cycle of the seminiferous epithelium in humans: a need to revisit? J Androl 2008; 29: 469-487.
35. World Health Organization. WHO Manual for the Standardised Investigation and Diagnosis of the Infertile Couple. Cambridge University Press: Cambridge, 2000.
36. Nieschlag E, Behre HM (eds), Andrology: Male reproductive health and dysfunction, 2nd ed. Berlin: Springer Verlag, Chapter 5, pp 83-87.
37. McMahon CG. Dapoxetine for premature ejaculation. Expert Opin Pharmacother 2010; 11: 1741-1752.
38. McMahon C, Kim SW, Park NC, Chang CP, Rivas D, Tesfaye F et al. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine. J Sex Med 2010; 7: 256-268.